| |
Newsroom /
Health and Fitness
/
Healthcare
/
Prosthetic Heart Valves
Prosthetic Heart Valves 
The Prosthetic Heart Valves Market is Expected to Grow at 5% over the Next Seven Years Prosthetic Heart
Hyderabad,
AP,
India
(prbd.net)
01/09/2010
"Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016"
The global prosthetic heart valves market is expected to grow to $1,731m in 2016, growing at a Compound Annual Growth Rate (CAGR) of 5% in the period 2009–2016. The global mechanical heart valves market is expected to decline at a CAGR of 1% in 2009–2016, to reach $301m by 2016. The global tissue heart valves market is expected to grow at a CAGR of 6% in the period 2009–2016, and is estimated to reach $1,430m by 2016. The market is expected to grow due to technological advancements in the durability of the tissue heart valves, which will drive adoption among young patients. The launch of transcatheter valves will also drive procedure volumes in patients where surgery was not possible earlier due to its risky nature.
For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Prosthetic-Heart-Valves--Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Medical_Devices
In recent years, several anti-calcification technologies have been developed to enhance the durability of tissue heart valves. Calcification of the prosthetic heart valves is the major cause of tissue valve failure. Treatments with surface active compounds, such as Amino Oleic Acid (AOA) and diphosphonates reduce the calcium binding sites and hence delay the calcification process. Medtronic’s Mosaic porcine tissue heart valves are treated with AOA and the Physiologic Fixation Process, which helps preserve the structure and function of the valves. A number of studies are currently underway to find more efficient ways of blocking the calcium binding sites to improve the long term durability of tissue heart valves. Other novel designs which will improve the hemodynamics of a bioprosthesis to better mimic the native heart valves are expected to improve market adoption. Another design innovation, the sutureless valve, is claimed to reduce surgery times and is less invasive compared to conventional stented valves.
Edwards Lifesciences is the undisputed market leader, with 48% of company share. The company has a range of tissue heart valves made from bovine pericardial tissue. The company also recently launched SAPIEN transcatheter heart valves in the European market after gaining Confirmite Europeanne (CE) approval. St. Jude Medical dominates the mechanical heart valves market and has an overall company share of 19% for the prosthetic heart valve market. The company has many marketed mechanical heart valves with the bi-leaflet design and some tissue heart valves. Medtronic, Inc. has a presence in both mechanical as well as tissue heart valves and has a 17% market share.
GlobalData’s medical equipment report, “Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global prosthetic heart valves market. The report provides market landscape, competitive landscape and market trends information the prosthetic heart valves market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Prosthetic-Heart-Valves--Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Medical_Devices
Visit our report store: http://www.globaldata.com
For more details Contact:
pressreleases@globaldata.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GlobalData is a global market intelligence services company providing information research and analysis products and services.
|